Search papers, labs, and topics across Lattice.
This study introduces EchoRisk, a comprehensive multicentre echocardiography dataset designed to address the challenge of automated risk stratification for therapy-induced cardiotoxicity in breast cancer patients. It includes 2,159 echocardiography videos from 422 patients, enabling three key tasks: estimating left ventricular ejection fraction, classifying LV dysfunction, and predicting early cardiotoxicity from baseline imaging. The authors establish strong baseline performance using an R(2+1)D video backbone with LSTM aggregation, highlighting the ongoing challenge of early cardiotoxicity prediction from pre-therapy videos.
Early prediction of therapy-induced cardiotoxicity from a single echocardiography video remains a significant challenge, despite strong performance in other cardiac assessments.
Therapy-induced cardiotoxicity is the leading non-oncological cause of treatment interruption in breast cancer patients, yet early, automated risk stratification from routine cardiac imaging remains an unsolved problem. We present EchoRisk, the first curated, multicentre, longitudinal echocardiography dataset with explicit cardiotoxicity labels, released as the primary technical reference for the EchoRisk-MICCAI 2026 challenge. The dataset comprises 422 patients enrolled in the EU-funded CARDIOCARE prospective study across five European sites, yielding 2,159 echocardiography videos across 1,123 clinical exams acquired at up to five longitudinal timepoints, alongside a dedicated cohort of 280 patients with baseline imaging for early cardiotoxicity prediction. Three clinically grounded tasks are defined: automated estimation of left ventricular ejection fraction from cine video (Task 1), classification of LV dysfunction from longitudinal imaging (Task 2), and early prediction of therapy-induced cardiotoxicity from pre-therapy baseline echocardiography alone (Task 3). For each task we specify the evaluation protocol, primary and secondary metrics, and ranking procedure. We establish baseline performance using an R(2+1)D video backbone with LSTM aggregation trained from Kinetics-400 pretrained weights, demonstrating strong discriminative performance for cardiac functional assessment and LV dysfunction classification, while early cardiotoxicity prediction from a single pre-therapy video remains a significant open problem for the community. The dataset, evaluation code, and baseline implementations are publicly available to serve as a benchmark for further collaboration, comparison, and the creation of task-specific architectures in cardio-oncology.
